AI automation, and more skilled staff are needed to ensure cancer patients can access potentially life-saving CAR T therapies.

Automated cell therapy manufacturing pioneer Cellares has hit a key milestone, gaining a current Good Manufacturing Practice (cGMP) stamp of approval for its Cell Shuttle factory-in-a-box, which is ...

The life science group Sartorius is launching an integrated system for the production and quality control (QC) of autologous cell therapies.

A new generation of automated technologies in cell and gene therapy manufacturing systems will help more people benefit according to research identifying high production cost as the main impediment to ...

The "Cell and Gene Therapy Manufacturing Market -- Growth, Share, Opportunities & Competitive Analysis, 2024 -- 2032" report has been added to the Credence Research Inc. offering. The global Cell and ...

The AMT designation gives Cellares’ clients using the Cell Shuttle priority review with the FDA leading to accelerated regulatory filings SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cellares, the ...

Anza, a subscription-based data and analytics software platform, released its Q2 2025 Domestic Content Insights report that reveals trends in domestic manufacturing of solar modules and battery energy ...